XML 31 R19.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Fair Value
6 Months Ended
Jun. 30, 2011
Fair Value [Abstract]  
Fair Value
Note 14 — Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The FASB provides accounting rules that classify the inputs used to measure fair value into the following hierarchy:
     
Level 1
  — Unadjusted quoted prices in active markets for identical assets or liabilities.
     
Level 2
  — Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.
     
Level 3
  — Unobservable inputs for the asset or liability.
The following table presents the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis as of June 30, 2011:
                                 
    Fair Value at June 30, 2011  
    Total     Level 1     Level 2     Level 3  
  | | | |
Assets:
                               
Cash and cash equivalents
  $ 632.8     $ 632.8     $     $  
Short-term investments
    29.0       29.0              
Foreign currency hedges
    0.5             0.5        
 
Total Assets
  $ 662.3     $ 661.8     $ 0.5     $  
 
 
                               
Liabilities:
                               
Foreign currency hedges
  $ 5.8     $     $ 5.8     $  
 
Total Liabilities
  $ 5.8     $     $ 5.8     $  
 
Cash and cash equivalents are highly liquid investments with maturities of three months or less when purchased and are valued at redemption value. Short-term investments are investments with maturities between four months and one year and are valued at amortized cost. The Company uses publicly available foreign currency forward and spot rates to measure the fair value of its foreign currency forward contracts.
The Company does not believe it has significant concentrations of risk associated with the counterparts to its financial instruments.
The following table presents the fair value hierarchy for those assets measured at fair value on a nonrecurring basis for the six months ended June 30, 2011 using Level 3 inputs:
                         
    Carrying     Fair Value        
    Value     Adjustment     Fair Value  
 
Assets held for sale:
                       
Inventories
  $ 4.7     $ (3.2 )   $ 1.5  
Equity investments
    6.9       (2.8 )     4.1  
 
Total assets held for sale
  $ 11.6     $ (6.0 )   $ 5.6  
 
     
Long-lived assets held and used:
                       
Fixed Assets
  $ 0.4     $ (0.4 )   $  
 
Total assets
  $ 12.0     $ (6.4 )   $ 5.6  
 
During the second quarter of 2011, the Company made a strategic decision to exit certain non-strategic aftermarket product lines. The Company plans to exit these product lines within twelve months. The Company wrote-down inventory with a carrying value of $4.7 million to $1.5 million, which reflects management’s best estimate of the value it would receive in a sale to a third party given the quantity and timing of the plan to exit these product lines.
The Company’s equity investment in International Component Supply LTDA (ICS) was reviewed for impairment during the first quarter of 2011. This equity investment was written down to its fair value of $4.1 million, resulting in an impairment charge of $1.8 million recognized in other expense, net for the first six months of 2011. The fair value of this investment was based on the estimated sales proceeds to be received from a third party if the Company were to sell its interest in the joint venture. During the second quarter of 2011, the Company sold its investment in ICS for $4.8 million, resulting in a gain of $0.5 million. The Company’s equity investment in Endorsia International.com (Endorsia) was also reviewed for impairment during the second quarter of 2011. This equity investment was completely written down, resulting in an impairment charge of $1.0 million recognized in other expense, net for the second quarter of 2011. The fair value of this investment was based on the estimated proceeds to be received by the parties that own Endorsia from the liquidation of this joint venture.
Financial Instruments
The carrying value of cash and cash equivalents, accounts receivable, commercial paper, short-term borrowings and accounts payable are a reasonable estimate of their fair value due to the short-term nature of these instruments. The fair value of the Company’s long-term fixed-rate debt, based on quoted market prices, was $478.8 million and $468.7 million at June 30, 2011 and December 31, 2010, respectively. The carrying value of this debt was $434.3 million and $430.4 million at June 30, 2011 and December 31, 2010, respectively.